Biogen (BIIB) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Biogen (BIIB) over the last 16 years, with Q4 2025 value amounting to $0.34.
- Biogen's Debt to Equity fell 857.05% to $0.34 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.34, marking a year-over-year decrease of 857.05%. This contributed to the annual value of $0.34 for FY2025, which is 857.05% down from last year.
- According to the latest figures from Q4 2025, Biogen's Debt to Equity is $0.34, which was down 857.05% from $0.01 recorded in Q2 2025.
- In the past 5 years, Biogen's Debt to Equity registered a high of $0.47 during Q4 2022, and its lowest value of $0.01 during Q2 2025.
- Its 5-year average for Debt to Equity is $0.29, with a median of $0.36 in 2025.
- In the last 5 years, Biogen's Debt to Equity surged by 41462.37% in 2022 and then crashed by 1966.3% in 2024.
- Biogen's Debt to Equity (Quarter) stood at $0.09 in 2021, then skyrocketed by 414.62% to $0.47 in 2022, then fell by 0.07% to $0.47 in 2023, then fell by 19.66% to $0.38 in 2024, then fell by 8.57% to $0.34 in 2025.
- Its Debt to Equity was $0.34 in Q4 2025, compared to $0.01 in Q2 2025 and $0.38 in Q4 2024.